首页|左卡尼汀注射液联合碳酸镧咀嚼片治疗慢性肾衰竭维持性血液透析患者的临床研究

左卡尼汀注射液联合碳酸镧咀嚼片治疗慢性肾衰竭维持性血液透析患者的临床研究

扫码查看
目的:分析左卡尼汀注射液联合碳酸镧咀嚼片治疗慢性肾衰竭维持性血液透析患者的临床效果。方法:选择2019年 10月—2022年 10月曹县人民医院肾内科收治的 120例慢性肾衰竭维持性血液透析患者为研究对象,根据随机数字表法将其分为对照组和研究组,各 60例。对照组给予左卡尼汀注射液治疗,研究组在对照组基础上联合碳酸镧咀嚼片治疗。分析并比较两组肾功能指标、骨代谢指标、钙磷代谢指标及不良反应发生情况。结果:治疗后,研究组肾功能指标均低于对照组,差异有统计学意义(P<0。05);研究组骨代谢指标中骨型碱性磷酸酶、甲状旁腺激素、成纤维细胞生长因子 23 含量均低于对照组,骨形态发生蛋白含量高于对照组,差异均有统计学意义(P<0。05);研究组钙磷指标均低于对照组,差异均有统计学意义(P<0。05);两组不良反应发生率比较,差异无统计学意义(P>0。05)。结论:左卡尼汀注射液联合碳酸镧咀嚼片能够有效改善慢性肾衰竭维持性血液透析患者肾功能,利于骨代谢及钙磷代谢水平恢复,且具有一定的安全性。
Clinical Study of Levocarnitine Injection Combined with Lanthanum Carbonate Chewable Tablets in the Treatment of Patients with Chronic Renal Failure Maintenance Hemodialysis
Objective:To analyze the clinical effects of Levocarnitine Injection combined with Lanthanum Carbonate Chewable Tablets in the treatment of patients with chronic renal failure maintenance hemodialysis.Methods:A total of 120 patients with chronic renal failure undergoing maintenance hemodialysis admitted to the Department of Nephrology in Cao County People's Hospital from October 2019 to October 2022 were selected as the study subjects.According to the random number table method,the patients were divided into a control group and a study group,with 60 cases in each group.The control group was treated with Levocarnitine Injection,and the study group was combined treated with Lanthanum Carbonate Chewable Tablets on the basis of the control group.The renal function indexes,bone metabolism indexes,calcium and phosphorus metabolism indexes and the occurrence of adverse reactions were analyzed and compared between the two groups.Results:After treatment,the renal function indexs of the study group were lower than those in the control group,the difference were statistically significant(P<0.05).The contents of bone alkaline phosphatase,parathyroid hormone and fibroblast growth factor-23 in the study group were lower than those in the control group,the content of bone morphogenetic protein was higher than that in the control group,the differences were statistically significant(P<0.05).The calcium and phosphorus indexes in the study group were lower than those in the control group,the differences were statistically significant(P<0.05).There was no statistical significance in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Levocarnitine Injection combined with Lanthanum Carbonate Chewable Tablets can effectively improve renal function in patients with chronic renal failure maintenance hemodialysis,is beneficial to the recovery of bone metabolism and calcium and phosphorus metabolism and has certain safety.

Chronic renal failureMaintenance hemodialysisLevocarnitine InjectionLanthanum Carbonate Chewable TabletsClinical effect

李月元

展开 >

山东省曹县人民医院肾内科,山东 菏泽 274400

慢性肾衰竭 维持性血液透析 左卡尼汀注射液 碳酸镧咀嚼片 临床疗效

2024

中国伤残医学
中国康复医学会,黑龙江省截瘫研究所

中国伤残医学

影响因子:0.451
ISSN:1673-6567
年,卷(期):2024.32(14)